3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
33
Carcinoma, Intraductal, Noninfiltrating
7
Breast Carcinoma In Situ
4
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Infertility
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasms by Site
1
Hypogonadism
1
Hot Flashes
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Ductal
1
Anovulation
1
Anatomic Stage III Breast Cancer AJCC v8
1
Interventions
Magnetic Resonance Spectroscopy
8
Specimen Handling
5
Nivolumab
5
selpercatinib
4
Iodine-124
4
Biopsy
4
pembrolizumab
3
binimetinib
3
Iodine-131
3
Cetuximab
3
ulixertinib
2
trametinib
2
omipalisib
2
lenvatinib
2
larotrectinib
2
durvalumab
2
defactinib
2
dabrafenib
2
Surveys and Questionnaires
2
Sunitinib
2
Radiosurgery
2
Ipilimumab
2
Immunoglobulin G
2
Gemcitabine
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
tremelimumab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Thyroid Neoplasms
×
Tamoxifen
×
90 days
×
Clear all
No trials found.